Ligand Pharmaceuticals (LGND) Other financing activities (2012 - 2026)
Ligand Pharmaceuticals (LGND) posted Other financing activities of $7.7 million for Q1 2026, up 138.48% sequentially from -$19.9 million in Q4 2025, and up 81.29% YoY from $4.2 million in Q1 2025.
Ligand Pharmaceuticals (LGND) Other financing activities (2012 - 2026) Analysis & Trends
Ligand Pharmaceuticals has reported Other financing activities for 15 years, with the latest figure at $7.7 million in Q1 2026.
- Quarterly Other financing activities rose 81.29% year-over-year to $7.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $226000.0 (up 102.04% YoY) and the FY2025 annual result came in at $47.5 million, changed N/A from the prior year.
- Other financing activities grew to $7.7 million in Q1 2026 per LGND's latest filing, from -$19.9 million in the prior quarter.
- Over five years, Other financing activities peaked at $21.4 million in Q3 2024 and troughed at -$46.3 million in Q4 2024.
- A 5-year average of $216125.0 and a median of $3.4 million in 2023 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 22680.0% in 2023, down 586.32% in 2023.
- Over 5 years, Other financing activities stood at $3.3 million in 2022, then tumbled by 586.32% to -$15.9 million in 2023, then sank by 190.48% to -$46.3 million in 2024, then surged by 57.0% to -$19.9 million in 2025, then surged by 138.48% to $7.7 million in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $7.7 million, -$19.9 million, and $8.2 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ligand Pharmaceuticals | 5.87 Bn | 4.51 Bn | 60.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 114.10 Mn |
| Jun 30, 2026 | 114.10 Mn |
| Mar 31, 2026 | 7.65 Mn |
| Mar 31, 2026 | 7.65 Mn |
| Dec 31, 2025 | -19.89 Mn |
| Dec 31, 2025 | -19.89 Mn |
| Jun 30, 2025 | 8.24 Mn |
| Jun 30, 2025 | 8.24 Mn |
| Mar 31, 2025 | 4.22 Mn |
| Mar 31, 2025 | 4.22 Mn |
| Dec 31, 2024 | -46.25 Mn |
| Dec 31, 2024 | -46.25 Mn |
| Sep 30, 2024 | 21.40 Mn |
| Sep 30, 2024 | 21.40 Mn |
| Jun 30, 2024 | 9.55 Mn |
| Jun 30, 2024 | 9.55 Mn |
| Mar 31, 2024 | 15.30 Mn |
| Mar 31, 2024 | 15.30 Mn |
| Dec 31, 2023 | -15.92 Mn |
| Dec 31, 2023 | -15.92 Mn |